Silence Therapeutics Correlations

SLN Stock  USD 7.67  0.21  2.82%   
The current 90-days correlation between Silence Therapeutics PLC and Eliem Therapeutics is 0.03 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Silence Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Silence Therapeutics PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Silence Therapeutics Correlation With Market

Average diversification

The correlation between Silence Therapeutics PLC and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Silence Therapeutics PLC and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silence Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Moving together with Silence Stock

  0.68JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.81LLY Eli Lilly Sell-off TrendPairCorr
  0.64MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.82PFE Pfizer Inc Aggressive PushPairCorr
  0.8RDY Dr Reddys LaboratoriesPairCorr
  0.75TAK Takeda PharmaceuticalPairCorr
  0.62LTRN Lantern PharmaPairCorr
  0.72ABBV AbbVie IncPairCorr
  0.86AMGN Amgen IncPairCorr
  0.64ANEB Anebulo PharmaceuticalsPairCorr
  0.62APGE Apogee Therapeutics,PairCorr
  0.63TEVA Teva Pharma Industries Sell-off TrendPairCorr

Moving against Silence Stock

  0.8VTRS ViatrisPairCorr
  0.71BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.7ESPR Esperion TherapeuticsPairCorr
  0.46BFRIW Biofrontera WarrantsPairCorr
  0.44GILD Gilead SciencesPairCorr
  0.41WAT WatersPairCorr
  0.74DXCM DexCom IncPairCorr
  0.71BSX Boston Scientific CorpPairCorr
  0.63MNMD Mind MedicinePairCorr
  0.48EW Edwards Lifesciences CorpPairCorr
  0.45ABT Abbott Laboratories Fiscal Year End 22nd of January 2025 PairCorr
  0.31CPRX Catalyst PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
MOLNCUE
INBXELYM
INBXCUE
  
High negative correlations   
ELYMCUE
MOLNELYM
MOLNINBX

Risk-Adjusted Indicators

There is a big difference between Silence Stock performing well and Silence Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Silence Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Silence Therapeutics Corporate Management

John StraffordAlliance DevelProfile
Rhonda HellumsChief OfficerProfile
Eric FloydVP AssuranceProfile
Gem HopkinsHead CommunicationsProfile
Gianine EspositoChief OfficerProfile
Giles MDHead VPProfile
Jrgen WittendorffVP ManufacturingProfile